Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas,1 Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland2
Received 10 July 2004/ Returned for modification 11 August 2004/ Accepted 28 September 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
While it is evident that histone modifications can have profound effects on transcription, it is much less clear as to how different histone codes are recognized and utilized. Current studies appear to suggest that once a code is generated, it can serve as an independent signal that allows the recruitment of a downstream regulatory protein(s). For instance, the bromodomain of TAFII250 and the chromodomain of HP1 are capable of binding acetylated histone tails and the K9 methylated H3 tails in vitro, respectively (2, 19, 21). Furthermore, K9 methylation is required for heterochromatin association of HP1 in cells (28). As a histone code involved in transcriptional activation, a recent study showed that acetylation of H4 on lysines 8 and 12 is sufficient for recruitment of TFIID at least in vitro, presumably through the double bromodomains in TAFII250 (1). However, exactly how these various codes are recognized and utilized in vivo is not clear.
Identified initially as corepressors for nuclear receptors such as thyroid hormone receptors (TR) and retinoic acid receptors (6, 17), N-CoR and SMRT are related proteins and have also been implicated in repression by many other transcription factors, including Mad/Mxi, BCL6/LAZ3, ETO, and CBF {for a review, see reference 14). Recent biochemical studies reveal that both SMRT and N-CoR exist in large protein complexes with an estimated size of 1.5 to 2 MDa and containing a set of core subunits, including histone deacetylase 3 (HDAC3), GPS2, TBL1 (transducin beta-like protein 1), and TBLR1 (TBL1-related protein) (16, 23, 36, 37, 41, 44). Human TBL1 and TBLR1 are highly related WD-40 repeat proteins, sharing 89% sequence identity. A redundant function of TBL1/TBLR1 in repression was revealed by a recent study using small interfering RNA (siRNA) to TBL1 and TBLR1 (41). Both TBL1 and TBLR1 can bind histones H2B and H4 in vitro (41), raising question as to whether these proteins are involved in potential histone code recognition during repression by SMRT/N-CoR complexes. The presence of TBL1 and TBLR1 in the HDAC3-containing SMRT/N-CoR complexes is reminiscent of the RbAp46 and RbAp48 (also highly related WD-40 repeat proteins) in the HDAC1/2-containing Sin3 and NURD complexes (40, 45, 46). In vitro reconstitution experiments indicated that in the NURD complex RbAp46/48 interacts directly with HDAC1/2 to form a core complex required for HDAC1/2 enzymatic activity (47). However, TBL1 and TBLR1 neither interact with HDAC3 directly nor are required for in vitro deacetylation of histones by HDAC3/SMRT or N-CoR complexes (15, 41, 44). Thus, although the presence of two related WD-40 repeat histone-binding proteins appears to be a conserved feature of the class I HDAC complexes, the functional significance of such conservation is not clear.
TBL1 and TBLR1 seem to be multiple functional proteins. Their association with SMRT/N-CoR complexes and involvement in transcriptional repression is underscored by the finding of the yeast SET3 complex as the homologous complex of SMRT/N-CoR (29). The yeast SET3 complex was shown to be involved in repression of the sporulation gene program and to contain Snt2, Sif2, and Hos2, which are the yeast homologs of the mammalian SMRT/N-CoR, TBL1/TBLR1, and HDAC3, respectively (29). On the other hand, the Drosophila TBL1 homolog, ebi, was genetically identified as a putative F-box protein involved in ubiquitin-dependent degradation of Tramtrack88 (8, 24). In addition, mammalian TBL1 (Ebi) was shown to collaborate with Siah1 in a novel pathway for ß-catenin degradation (25). More recently, both TBL1 and TBLR1 were reported to be required for transcriptional activation by nuclear receptors and other regulated transcription factors (27). A role in cofactor exchange through ubiquitin-dependent protein degradation was proposed to explain such unexpected functions for TBL1 and TBLR1 in transcriptional activation (27).
Here we present evidence for a novel role of TBL1/TBLR1 in histone code reading and targeting of the HDAC3-containing SMRT/N-CoR to chromatin. In addition, we show that RbAp46/48 in the Sin3A complex have a similar function. We also present evidence that TBL1 and TBLR1 are not absolutely required for T3-dependent activation by TR.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture and siRNA experiments.
Cell culture and siRNA treatment were essentially as described previously (41). For transfection of siRNAs, HeLa
2 cells were first cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% charcoal-stripped serum for 3 days and then transfected at a cell confluency of
40 to 50% with the indicated amounts of siRNA by using the TransIT-TKO transfection reagent (Mirus) according to the manufacturer's instructions. Two days after transfection, cells were collected and processed for Western analysis, immunostaining, and reverse transcription-PCR (RT-PCR) or chromatin immunoprecipitation (ChIP) as indicated. For experiments with T3 and TSA,
2 cells first were seeded at a density 4 x 105 cells/100-mm-diameter tissue culture dish. After 24 h of incubation, the culture medium was replaced by DMEM with 10% charcoal-stripped fetal calf serum (CS-FCS) (Gemini Bio-Products) for 3 days, followed by replacement of the medium with fresh CS-FCS supplemented with 10 nM thyroid hormone (T3) or 300 nM trichostatin A (TSA) for up to 60 min. For the experiments involving both siRNAs and T3 or TSA, T3 or TSA was added 2 days after siRNA transfection and incubated for 1 h or as indicated for ChIP assays and for 6 h for RT-PCR analysis. For the treatment with lysine-coenzyme A (Lys-CoA), cells were permeabilized with transport buffer (20 mM HEPES-KOH [pH 7.3], 110 mM potassium acetate, 2 mM magnesium acetate, 1 mM EGTA, 2 mM dithiothreitol) containing digitonin (35 µg/ml) on ice for 5 min. After 1 h of incubation with 50 µM of Lys-CoA, the transport buffer was changed to CS-FCS containing 10 nM T3 for 1 h. All siRNAs were synthesized by Dharmacon Research (Lafayette, Colo.). The siTBL1 used contains two siRNAs, 5'-AAGAGAATGGAGCACATGAAA-3' and 5'-AAGATGAGCATAACCAGTGAC-3'. The siTBLR1 sequence is 5'-AAGGCCCTATATTTGCATTAA-3'. The siHDAC3 used was a SMART pool purchased from Dharmacon.
RNA extraction, RT-PCR, and ChIP. RNA extraction, RT-PCR, and ChIP were performed as described previously (42). The antibodies against various modified histones were purchased from Upstate Biotechnology (22). The antibodies against SMRT/N-CoR complexes were as described previously (42). Primers used for ChIP analysis were as follows: P1 pair primers, 5'-GGAGGCCAAGGCGGGTAGGTCATCT-3' and 5'-CCGGGTCAGGGGAAGGAGTCAGGTCA-3'; P2 pair primers, 5'-AGGCCACAGCACCCAATCAAGA-3' and 5'-AAAGACCGTGTGCAGGGAATGTG-3'.
Western blotting and immunostaining.
Western blotting analyses were performed primarily as described previously (42), using antibodies as indicated. For immunostaining,
2 cells were grown on coverslips in six-well plates and then transfected with 5 nM siTBL1, siTBLR1, or both by using Lipofectamine 2000 (Invitrogen) according to the manufacturer's suggestions. Following 24 h of incubation,
2 cells on coverslips were transferred to a new plate with fresh DMEM containing 10% fetal bovine serum (Gemini Bio-Products). After an additional 2 days of incubation, the transfected cells were washed in phosphate-buffered saline (PBS), fixed with 3% paraformaldehyde in PBS for 15 min, washed, permeabilized in 0.25% Triton X-100 for 5 min, and blocked with 10% normal goat serum. Next, cells were incubated with anti-TBL1 or -TBLR1 for 2 h at 37°C. After being washed with PBS, the cells were incubated with fluorescein isothiocyanate-conjugated goat anti-rabbit immunoglobulin G (Molecular Probes) as the secondary antibody (1:200) for 2 h at room temperature. The slides were mounted on a microscope stage and visualized with an LSM 510 fluorescence microscope (Zeiss). Images were analyzed by using LSM imaging software (Zeiss).
In vitro pull-down assay. GST pull-down experiments for analysis of protein-protein interaction were as described previously (41), using GST fusion proteins and in vitro-translated [35S]methionine-labeled proteins as indicated. For the competition assay using purified histone, 200 ng, 600 ng, or 1.8 µg of hypo- or hyperacetylated histone was preincubated with 35S-H2B or -H4 at 4°C for 1 h before incubation with GST-TBL1. For histone tail peptide binding and competition assays, all peptides were synthesized and purified by Genemed Synthesis Inc. (South San Francisco, Calif.). The sequence of each peptide was as indicated in Fig. 5A. For biotinylated histone peptide binding assay, 1 µg of biotinylated H4 or acetylated H4 tail peptides was immobilized on streptavidin-agarose beads (Invitrogen), and then pull-down assays were performed with in vitro-translated proteins as indicated. For peptide competition assay, 1, 5, or 10 µg of each lysine residue-modified peptide was preincubated with 1 µg of either biotinylated H4 peptide or 35S-H4, followed by incubation with either 35S-TBL1 or GST-TBL1. The binding assays were performed at 4°C for 2 h in binding buffer (20 mM Tris-HCl [pH 7.1], 120 mM KCl, 1 mM dithiothreitol, 1 mM EDTA, 0.1% NP-40, 10% glycerol) containing 1 mM phenylmethylsulfonyl fluoride. Each experiment was repeated at least three times to ensure reproducibility, and a representative result was scanned and quantified by using a UMAX ASTRA 2400S scanner and NIH IMAGE 6.2 software.
|
| RESULTS |
|---|
|
|
|---|
2 cell line which constitutively expresses a FLAG-tagged human TR
(32). The D1 gene promoter contains a well-characterized thyroid hormone response element (TRE) located at positions 105 to 130 relative to the transcriptional start site (Fig. 1A). In HeLa
2 cells, this gene is actively repressed by TR
in the absence of T3 and activated in the presence of T3 (32, 41). We used ChIP assays to determine the association of the SMRT/N-CoR complexes with the D1 promoter. We found that SMRT, N-CoR, and their associated proteins HDAC3, TBL1, TBLR1, and IR10 (associated only with N-CoR) were associated with the D1 promoter in untreated HeLa
2 cells but not in those treated with 50 nM T3 for 1 h (Fig. 1B, P1). As controls, the SMRT and N-CoR complexes were not found to associate with the PS2 promoter (data not shown) or with the coding region of the D1 genes in the same experiments (Fig. 1B, P2). Furthermore, in agreement with the presence of SMRT/N-CoR complexes, ChIP assays using antibodies specifically against various modified histones indicated that the D1 promoter was associated with hypoacetylated histones H3 and H4 in the absence of T3 (Fig. 1D, compare lane 1 with lane 2). Consistent with the idea that TR binds constitutively to TRE in chromatin, ChIP assay using a TR
-specific antibody detected the presence of TR under both conditions. These results therefore established that repression of the D1 gene by unliganded TR is correlated with the recruitment of SMRT/N-CoR complexes.
|
2 cells were first transfected with siHDAC3 or a control siRNA for 3 days and then processed for ChIP assays to determine the histone modifications over the D1 promoter. The ChIP results showed that treatment of
2 cells with siHDAC3 did not affect TR binding but led to a significant increase of the levels of acetylated H3 and H4 (Fig. 1D, compare lane 3 with lane 4). The control Western analysis showed that siRNA treatment led to a more than 90% reduction of HDAC3 protein and that knocking down HDAC3 did not affect the global acetylation levels of histones H3 and H4 (Fig. 1C). These results reveal a crucial role for HDAC3 in mediating deacetylation by SMRT/N-CoR complexes, in full agreement with the fact that HDAC3 is the major HDAC associated with SMRT/N-CoR complexes (16, 23). Taking these results together, we conclude that SMRT/N-CoR complexes are targeted to the D1 gene promoter by unliganded TR and contribute to histone hypoacetylation primarily through its associated HDAC3 activity.
|
2 cells with siTBL1, siTBLR1, or both led to specific knockdown of TBL1, TBLR1, or both (Fig. 1E). We then examined the effect of these siRNAs on the repression function of SMRT/N-CoR complexes by analyzing D1 gene expression. Quantitative real-time RT-PCR (qPCR) analysis (Fig. 1F) showed that treatment with either siTBL1 or siTBLR1 alone had little, if any, effect on D1 gene expression. However, the combination of siTBL1 and siTBLR1 led to a substantial derepression of the D1 gene (
3.3-fold increase). A similar level of de-repression was observed when siHDAC3 was used (data not shown; see Fig. 6E). Under the same conditions, a 6-h T3 treatment resulted in
5-fold activation. These results establish that TBL1 and TBLR1 are functionally redundant but together are essential for D1 gene repression by unliganded TR. As expected, no effect on D1 gene expression was observed when the regular HeLa cells lacking FLAG-TR
were used in this experiment (data not shown).
|
, SMRT, N-CoR, and HDAC3 (data not shown) (41). By immunofluorescence staining we also observed no effect on the nuclear location of N-CoR and HDAC3 upon knockdown of both TBL1 and TBLR1 (Fig. 2A), whereas the specificity and knockdown of TBL1 and TBLR1 were confirmed (Fig. 2B). Furthermore, coimmunoprecipitation experiments showed that siTBL1 and siTBLR1 treatment did not affect the association of HDAC3 and GPS2 with N-CoR (Fig. 2C) and SMRT (data not shown). In further support, gel filtration analysis of the cellular extracts derived from double-siRNA-treated cells showed cofractionation of HDAC3 with N-CoR, although the complex became smaller (Fig. 2D), a result expected with the removal of TBL1 and TBLR1. Thus, removal of TBL1 and TBLR1 does not appear to affect the expression and subcellular localization of N-CoR and HDAC3 or the association of the core subunits HDAC3 and GPS2 with SMRT and N-CoR, although we cannot exclude the possibility that the association of other components in the SMRT and N-CoR complexes may be affected.
|
2 cells were first treated with siRNAs against TBL1 and TBLR1 alone or in combination, and the association of the corepressor complexes with the D1 promoter was determined by ChIP assays. Treatment of cells with siRNA against TBL1 or TBLR1 led to a specific inhibition of its own association with the D1 promoter but had little effect on the association of other components of the complexes (Fig. 3A). Significantly, simultaneous reduction of TBL1 and TBLR1 led to inhibition of the association of the entire complexes with the D1 promoter (Fig. 3A). Thus, these results uncover an essential role for TBL1/TBLR1 in targeting SMRT/N-CoR complexes to the D1 promoter by unliganded TR.
|
nor its binding to the D1 promoter was affected by any of these siRNA treatments (data not shown). Collectively these results demonstrate that TBL1 and TBLR1 are functionally redundant but essential for targeting of SMRT and N-CoR complexes to the D1 promoter by unliganded TR.
TBL1 and TBLR1 are not absolutely required for T3-dependent activation.
Because TBL1 and TBLR1 were recently shown to be required for transcriptional activation by various nuclear receptors (27), we next examined the effect of siTBL1 and siTBLR1 on T3-dependent activation. For this purpose, HeLa
2 cells were first treated with the indicated siRNA for 72 h and then induced with 50 nM T3 for 6 h. Total RNA was prepared from each sample, and the responses of three TR target genes (11), namely, D1, ADRB2 (ß-2 adrenergic receptor), and BCL3 (B-cell lymphoma 3-encoded protein) to T3 were assessed by semiquantitative RT-PCR. The results in Fig. 3C show that treatment with siTBL1 or siTBLR1 alone did not appreciably affect activation induced by T3 for all three genes. However, double siRNA treatment led to a substantial derepression of all three TR target genes. Under this condition, no significant T3-dependent activation was observed, most likely as a result of loss of repression rather than loss of activation. Indeed, qPCR analysis confirmed that siTBL1 and siTBLR1 alone did not affect the T3 induction of the D1 gene and that T3 treatment led to a further increase of D1 transcription even in the case of double siRNA treatment (from
3.6- to
5.1-fold) (Fig. 3D). Thus, in our experimental setting, TBL1 or TBLR1 does not appear to be required for T3-dependent activation of all three TR target genes we have tested.
TBL1 and TBLR1 recognize and bind preferentially to hypoacetylated H2B and H4. We recently showed that among four core histones, TBL1 and TBLR1 bind preferentially to histones H2B and H4 (41). Thus, we hypothesized that TBL1 and TBLR1 could play a role in targeting SMRT/N-CoR complexes to chromatin via their interaction with histones. We first sought to determine whether binding of TBL1 and TBLR1 to histones requires the histone N-terminal tails. For this purpose, we performed in vitro pull-down assays using GST-TBL1 and in vitro-translated full-length or tail-less H2B and H4. The results in Fig. 4A indicate that the N-terminal tail is required for TBL1 to bind H2B and H4. Similar results were obtained when GST-TBLR1 was used (data not shown).
|
26.7 times less efficient) (Fig. 4C, lower panel). Thus, TBL1 and TBLR1 bind preferentially to hypoacetylated histones, presumably H2B and H4. We next wished to substantiate the above binding results by an independent assay. Because acetylation on H4 has a more pronounced effect on binding of TBL1, we focused our effort on H4. We first compared the binding of TBL1 and TBLR1 to the chemically synthesized histone H4 tail peptide (amino acids 1 to 30) without acetylation (H4) or with acetylation at lysines 5, 8, 12, and 16 (acH4). To facilitate the pull-down assay, a biotin residue together with a short linker (GGK) was added at the C termini of the peptides. These peptides were immobilized to streptavidin-agarose beads and used to pull down in vitro-translated, [35S]methionine-labeled TBL1 and TBLR1. As shown in Fig. 5B, TBL1 and TBLR1 bound readily to the H4 tail but not to the acetylated H4 tail. These results confirmed a marked effect of acetylation on binding of TBL1 and TBLR1 to histone H4 tails.
To test whether the binding of TBL1/TBLR1 is determined by a specific deacetylated lysine reside in the H4 tail, we set up another competition assay. In this experiment we challenged the binding of in vitro-translated [35S]methionine-labeled H4 to GST-TBL1 with synthetic H4 peptides containing no acetylation, acetylation at all four lysine residues, or acetylation at each individual lysine (Fig. 5C). The results show that the AcK5, AcK8, and AcK12 peptides competed almost as efficiently as the unacetylated H4 tail and that the AcK16 peptide competed less efficiently (Fig. 5C). As expected, the AcH4 tail competed poorly. Thus, among four lysines tested, acetylation on lysine 16 has a clear effect on binding of TBL1. However, multiple lysines appear to contribute to the binding, as the acK16 peptide was still much more efficient in competing binding of H4 than the acH4 peptide.
Histone hypoacetylation is required for stable association of SMRT/N-CoR complexes to chromatin by unliganded TR.
Given the above results that TBL1 and TBLR1 are required for targeting SMRT/N-CoR complexes to chromatin and that TBL1 and TBLR1 bind preferentially to hypoacetylated histones, we wished to determine the role of histone acetylation, if any, in targeting SMRT/N-CoR complexes to the D1 promoter by unliganded TR. Toward this end, we tested the ability of unliganded TR to recruit SMRT/N-CoR complexes to the D1 promoter under the condition where histone deacetylation was blocked by TSA. HeLa
2 cells were treated with or without T3 or TSA for 1 h, and the association of SMRT/N-CoR complexes with the D1 promoter was analyzed by ChIP assays. The results in Fig. 6A showed that, like T3 treatment, TSA treatment resulted in dissociation of the SMRT/N-CoR complexes from the D1 promoter. To test whether TSA treatment also affected binding of TR, we performed ChIP assay with an anti-FLAG antibody. The results in Fig. 6B showed that the binding of TR to the D1 promoter was not affected by TSA treatment. The signal detected with FLAG antibody reflected the binding of TR, because ChIP assay with the parental HeLa cells (without FLAG-TR
) yielded only background signal (Fig. 6B). Furthermore, TSA treatment did not appear to induce degradation of the N-CoR complex, as Western blotting showed that TSA did not affect the levels of N-CoR and HDAC3 in the HeLa
2 cells (Fig. 6C).
To better understand the effect of TSA on release of SMRT/N-CoR complexes from the D1 promoter, we compare the histone modification status under various conditions. As shown in Fig. 6D, TSA treatment led to increased levels of acetylation on both H3 and H4. The increase in histone acetylation is comparable to that observed after siHDAC3 or siTBL1/siTBLR1 treatment. Together, these results suggest that induction of histone acetylation is likely sufficient to dissociate the SMRT/N-CoR complexes from the chromatin, although the potential involvement of other histone modifications could not be formally excluded. Finally, assuming that TSA did not affect the direct interaction between unliganded TR and SMRT/N-CoR, these results imply that the interaction between unliganded TR and SMRT/N-CoR alone is insufficient for the stable recruitment of SMRT/N-CoR complexes. In support of this, we observed no effect of TSA on the interaction between unliganded TR and SMRT/N-CoR in an in vitro GST-TR pull-down assay, as described previously (data not shown) (23). It is noteworthy that a more pronounced effect on histone acetylation was repeatedly observed for T3 treatment in comparison to TSA (Fig. 6B, compare lane 2 to the other lanes), presumably as a combined result of corepressor complex dissociation and subsequent active recruitment of coactivators by liganded TR (see Fig. 7D).
|
RbAp46 also binds preferentially to hypoacetylated histones.
Since RbAp46 and RbAp48 in Sin3 and Mi-2/NuRD complexes are analogous to TBL1 and TBLR1 in SMRT/N-CoR complexes, we next tested whether RbAp46 also binds preferentially to the hypoacetylated histones. We have shown previously that RbAp46 binds to histone H3 rather than H4 (41). Using a competition experiment set up as for Fig. 4C, we found that core histones derived from TSA-untreated cells competed much more efficiently (
40-fold) than those from TSA-treated cells (Fig. 7A). Thus, RbAp46, much like TBL1 and TBLR1, also binds preferentially hypoacetylated histones (presumably H3).
Targeting of the Sin3A complex to pericentromeric chromatin is dependent on histone hypoacetylation.
To test whether histone acetylation also influences targeting of the Sin3 complex to chromatin, we made use of our recent finding that the Sin3A complex is present and actively involved in the maintenance of the hypoacetylated status of the pericentric heterochromatin (39). As shown in Fig. 7B, the association of Sin3A with the
-satellite sequence in the chromosome 4 centromere was diminished after TSA treatment, which led to increases in acetylation of H3 and H4. Similar results were observed when the association of Sin3A with the pericentromeric sequences of chromosomes 10 and 11 was analyzed (data not shown). These results suggest that interaction between HDAC complexes and hypoacetylated histones may have a general role in stabilizing the association of HDAC complexes with chromatin. Given their in vitro interaction with hypoacetylated histones (Fig. 7A), we suggest that RbAp46/48 in the Sin3A complex are likely to be the proteins that recognize and bind to the hypoacetylated histone tails in pericentric heterochromatin.
Histone hypoacetylation alone is not sufficient for stable association of SMRT/N-CoR complexes with chromatin.
Recent studies suggest that H3-K9 methylation serves as an epigenetic marker to recruit heterochromatin protein I (HP1) for long-term repression (2, 21, 26, 28). We next tested whether the interaction of SMRT/N-CoR and Sin3A complexes with hypoacetylated histones alone is sufficient to recruit and/or maintain the association of the corepressor complexes with chromatin. We find that the histone hypoacetylation alone is not sufficient to recruit or maintain the binding of the corepressor complexes, based on the following evidence. First, as shown in Fig. 8A, ChIP assays revealed the absence of Sin3A in the D1 promoter and, conversely, the absence of SMRT/N-CoR in the
-satellite of chromosome 4, although both loci were associated with hypoacetylated H3 and H4. This result implies that histone hypoacetylation itself is not sufficient for recruiting either corepressor complex. If histone hypoacetylation is sufficient for binding of SMRT/N-CoR corepressor complexes, we would expect to see the presence of SMRT/N-CoR in the
-satellite of chromosome 4. Second, in a time course experiment where we followed the dissociation of SMRT and N-CoR and changes in histone acetylation upon T3 treatment (Fig. 8B), we found that the dissociation of SMRT and N-CoR from the D1 promoter was a rapid event, occurring within 5 min upon addition of T3. However, the increase in histone acetylation was not detected until 10 min after T3 treatment, indicating that the dissociation of SMRT/N-CoR complexes occurred prior to an increase in histone acetylation. This result implies that in the absence of unliganded TR and SMRT/N-CoR interaction, the interaction between SMRT/N-CoR and hypoacetylated histones is not sufficient to maintain their chromatin association. It is noteworthy that the recruitment of coactivator SRC-1 could be detected as early as 5 min, which may recruit CBP/p300 and account for the subsequent increase in histone acetylation. Consistent with a previous publication (32), the recruitment of TRAP220, a subunit of the TRAP/DRIP/SMCC complex was not detected until 30 min after T3 treatment.
Next we tested whether addition of T3 would lead to dissociation of SMRT/N-CoR under conditions where T3-induced histone acetylation is inhibited. Previous studies suggest that histone acetylation upon T3 treatment is most likely a result of T3-dependent recruitment of CBP/p300 (18). To inhibit T3-induced histone acetylation, we first permeated HeLa
2 cells with digitonin and preincubated the cells with Lys-CoA, a potent CBP/p300-selective hypoxanthine-aminopterin-thymidine inhibitor (50 µM), for 1 h before the addition of T3. The cells were then taken at various time points after addition of T3, and the association of N-CoR with the D1 promoter was determined by ChIP assay. As shown in Fig. 8C, addition of Lys-CoA indeed blocked the T3-dependent increase of H4 acetylation as revealed by ChIP assay. However, much of the N-CoR was dissociated from the chromatin under these conditions, suggesting that blocking histone acetylation in the absence of unliganded TR and N-CoR interaction is by itself insufficient to fully maintain the association of the N-CoR complex with chromatin. Together these data indicate that the interaction with hypoacetylated histones alone is neither sufficient to recruit nor able to maintain the chromatin association of the SMRT/N-CoR complexes.
Role of histone deacetylation by HDAC3 in targeting SMRT/N-CoR complexes to chromatin. Thus far our results indicated that targeting of SMRT/N-CoR complexes to the D1 promoter by unliganded TR also requires TBL1/TBLR1 (Fig. 3) and hypoacetylated histones (Fig. 6). As HDAC3 is critically important for the observed histone deacetylation over the D1 promoter (Fig. 1D), we next tested the role of HDAC3 in targeting SMRT/N-CoR complexes to the D1 promoter. As shown in Fig. 8D by ChIP assays, treatment with siHDAC3 significantly impaired the association of SMRT, N-CoR, and TBL1 with the D1 promoter, whereas treatment with siHDAC1 had no effect. Thus, deacetylation by HDAC3 has a critical role in targeting SMRT/N-CoR complexes to the D1 promoter. Control coimmunoprecipitation experiments showed that siHDAC3 treatment did not affect expression or formation of the remaining SMRT/N-CoR complexes (data not shown) (41).
| DISCUSSION |
|---|
|
|
|---|
Several lines of evidence indicate that the role of TBL1/TBLR1 in targeting SMRT/N-CoR complexes to the D1 promoter likely lies in their interaction with hypoacetylated histones. First, TBL1 and TBLR1 are histone-binding proteins that bind preferentially to hypoacetylated histones (Fig. 4 and 5). Second, histone hyperacetylation induced by TSA treatment resulted in dissociation of the SMRT/N-CoR complexes from the D1 promoter in the absence of T3 (Fig. 6A). Third, knockdown of HDAC3 impaired the targeting of SMRT/N-CoR to the D1 promoter (Fig. 8D). Together these results suggest that the interaction between TBL1/TBLR1 and hypoacetylated histones is important for targeting SMRT/N-CoR complexes to chromatin.
Two-interaction, feed-forward working model for targeting of SMRT/N-CoR complexes to chromatin by unliganded TR. While both TBL1/TBLR1 and hypoacetylated histones are essential, they are insufficient for targeting SMRT/N-CoR to chromatin in the absence of the interaction between unliganded TR and SMRT/N-CoR (Fig. 8A, B, and C). Similarly, unliganded TR alone cannot recruit SMRT/N-CoR complexes to the D1 promoter in the absence of TBL1/TBLR1 (Fig. 3A) or hypoacetylated histones (Fig. 6A). Taken together, our data support a two-interaction, feed-forward working model (Fig. 9) for targeting SMRT/N-CoR complexes to chromatin. First, unliganded TR interacts directly with SMRT/N-CoR. This interaction, although not sufficient for the stable recruitment of the complexes, initiates limited histone deacetylation. TBL1/TBLR1 then recognizes and binds the resultant deacetylated histone tails. This binding stabilizes the association of the SMRT/N-CoR complexes with chromatin and allows deacetylation of additional histones. The subsequent stable (but able to be dynamic) association of SMRT/N-CoR and extensive deacetylation finally lead to repression and maintenance of repression. The result that knockdown HDAC3 impaired the targeting of SMRT/N-CoR complexes to the D1 promoter (Fig. 7D) provides further support for this working model.
|
Role of TBL1/TBLR1 in protein degradation and transcriptional activation. In addition to their association with SMRT/N-CoR and role in repression, TBL1/TBLR1 and their Drosophila homolog, ebi, have also been implicated as putative F-box proteins involved in degradation of Tramtrack88 and ß-catenin (8, 24, 25). More recently, TBL1 and TBLR1 were shown to be required for transcriptional activation by nuclear receptors and other transcription factors (27). In this case, TBL1 and TBLR1 were proposed to be required for corepressor-coactivator exchange that is essential for transcription. In our hands, TBL1 and TBLR1 do not appear to have any significant effect on the stability of SMRT and N-CoR proteins (data not shown). One likely explanation is that TBL1 and TBLR1 are context-dependent multifunctional proteins. If they are associated with proteins such as Siah-1 and SIP or an adaptor protein like Phyllopod (24, 25), TBL1 and TBLR1 can function as F-box proteins involved in degradation. Within the SMRT/N-CoR complexes, TBL1/TBLR1 may not be able to interact with these adaptor proteins, which are required for ubiquitin-dependent degradation, and thus are not involved in protein degradation. Indeed, during our multiple efforts at purification of SMRT and N-CoR complexes, we have not identified the presence of Siah-1 or SIP. However, we showed previously by gel filtration analysis that while SMRT and N-CoR proteins in HeLa nuclear extracts all existed in large protein complexes (1.5 to 2 MDa), there were fractions containing TBL1 but without SMRT/N-CoR (23). We are currently testing whether this smaller TBL1 complex(es) may contain Siah-1 and/or SIP.
In contrast to the results in a recent report (27), we found that knockdown of TBL1 or TBLR1 individually by siRNA had no significant effect on T3-dependent activation of three TR target genes that we tested (Fig. 3C and D). These results could not be explained by inefficiency of the siRNAs we used, because knockdown was confirmed by both Western analysis (Fig. 1E) and ChIP assay (Fig. 3A), and the same results were observed when multiple different siRNAs against TBL1 or TBLR1 were tested. In support of this, we did not observe any significant effect of knockdown of TBL1 or TBLR1 on androgen-dependent activation of several AR target genes in LNCaP cells (H.-G. Yoon and J. Wong, unpublished data). In addition, we did not observe any significant association of TBL1 or TBLR1 with the D1 promoter upon T3 treatment (Fig. 1B). Together, our data argue against an essential role for TBL1 or TBLR1 in transcriptional activation by TR. Whether the requirement for TBL1 or TBLR1 in transcriptional activation is a cell type- or context-dependent phenomenon remains to be solved in the future.
A common role for WD-40 repeat proteins in various corepressor complexes? A common feature of all three major mammalian class I HDAC-containing complexes (Sin3A, NURD, and SMRT/N-CoR) is the presence of two highly related WD-40 repeat proteins (RbAp46/48 in Sin3A and NURD and TBL1/TBLR1 in SMRT/N-CoR). The association of WD-40 repeat proteins with HDACs extends to Drosophila and mammalian Groucho (5) and yeast TUP1 (10, 38). For these two proteins, their repression function correlates with their histone binding activity (5, 9). The role of this family of proteins in targeting corepressor complexes to chromatin for repression in vivo was first revealed by studies on yeast TUP1 by Davie et al. They showed that the proper chromatin targeting of TUP1/SSN6 in yeast is sensitive to both histone tail mutations and histone deacetylase mutations (7). In this study, we show that targeting of SMRT/N-CoR complexes to the D1 promoter by unliganded TR requires TBL1/TBLR1 (Fig. 3A) and is also sensitive to TSA treatment (Fig. 6A). Similarly, we show that the association of the Sin3A complex with pericentromeric heterochromatin is also sensitive to TSA (Fig. 7B) and that RbAp46 binds preferentially to hypoacetylated histones, presumably H3, in vitro (Fig. 7A). Thus, interaction with hypoacetylated histones seems to be a conserved function among WD-40 repeat proteins that are present in various corepressor complexes. It is therefore tempting to suggest that, like TBL1/TBLR1 in SMRT/N-CoR complexes, all of these WD-40 repeat proteins may function in a feed-forward mode to stabilize the chromatin association of their corresponding corepressor complexes. It will be interesting in the future to determine whether Sif2, the yeast homolog of TBL1/TBLR1 (29), also binds histones and has a similar role in targeting the yeast SET3 complex for repression.
Reading and function of the histone code. A key issue in the histone code hypothesis is exactly how each code or modification is recognized and utilized. One possibility is that once a histone code is generated, it serves as an independent signal for the binding of a downstream regulatory protein(s), which in turn specifies the function of the code. The findings that the bromodomain of TAFII250 binds specifically acetylated H4 tails and that the chromodomain of HP1 and polycomb differentially recognizes K9- versus K27-methylated H3 tail provide evidence for this idea (2, 4, 13, 19, 21). In this study, we show that while TBL1/TBLR1 can bind hypoacetylated H4 tail in vitro, in vivo such an interaction occurs only in the context of unliganded TR-SMRT/N-CoR interaction and histone hypoacetylation alone is not sufficient to recruit the SMRT/N-CoR complexes to chromatin. Thus, in this case the histone code involved does not seem to serve as an independent signal in a signaling cascade to specify the interaction with a downstream regulatory protein(s). Rather, it functions in a feed-forward mode (Fig. 9) to provide additional interactions to stabilize the recruitment of the corepressor complexes. This feed-forward, two-interaction mode provides at least the following two advantages for regulation: cooperation and specificity. As indicated previously (31), sophisticated functional pathways are often assembled through multiple weak protein-protein interactions that together provide sufficient stability and duration for a biological response. Such a scheme also lends itself well to rapid transcriptional activation in response to hormone, since breaking the interaction between TR and SMRT/N-CoR is sufficient to dislodge the corepressor complexes from the TR target gene (Fig. and 7C 8B). Furthermore, such a mode of interaction would provide specificity by excluding the binding of the SMRT/N-CoR complexes to other hypoacetylated loci. If TBL1/TBLR1 or RbAp46/48 can read hypoacetylated histones independently, one would expect SMRT/N-CoR to associate with pericentromeric heterochromatin and the Sin3A complex to associate with the D1 promoter. Our results show that while the Sin3A complex was found to associate with pericentromeric heterochromatin, the association of SMRT/N-CoR was not detected (Fig. 8A). Conversely, Sin3A was not detected in the hypoacetylated D1 promoter (Fig. 8A). These results suggest that the Sin3A complex may follow the same feed-forward mechanism for targeting to a specific locus for repression. In this regard, the reading of the histone code in the context of other interactions is unlikely to be unique to the SMRT/N-CoR complexes but rather is likely to be a common mechanism for how various histone codes are read and utilized.
| ACKNOWLEDGMENTS |
|---|
2 cell line and Andrew Dennis for technical assistance in qPCR analysis. This work is supported by NIH grants DK58679 to J.W. and GM62437 to P.A.C.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Bannister, A. J., P. Zegerman, J. F. Partridge, E. A. Miska, J. O. Thomas, R. C. Allshire, and T. Kouzarides. 2001. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410:120-124.[CrossRef][Medline]
3. Berger, S. L. 2002. Histone modifications in transcriptional regulation. Curr. Opin. Genet. Dev. 12:142-148.[CrossRef][Medline]
4. Cao, R., L. Wang, H. Wang, L. Xia, H. Erdjument-Bromage, P. Tempst, R. S. Jones, and Y. Zhang. 2002. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298:1039-1043.
5. Chen, G., and A. J. Courey. 2000. Groucho/TLE family proteins and transcriptional repression. Gene 249:1-16.[CrossRef][Medline]
6. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.[CrossRef][Medline]
7. Davie, J. K., R. J. Trumbly, and S. Y. Dent. 2002. Histone-dependent association of Tup1-Ssn6 with repressed genes in vivo. Mol. Cell. Biol. 22:693-703.
8. Dong, X., L. Tsuda, K. H. Zavitz, M. Lin, S. Li, R. W. Carthew, and S. L. Zipursky. 1999. ebi regulates epidermal growth factor receptor signaling pathways in Drosophila. Genes Dev. 13:954-965.
9. Edmondson, D. G., M. M. Smith, and S. Y. Roth. 1996. Repression domain of the yeast global repressor Tup1 interacts directly with histones H3 and H4. Genes Dev. 10:1247-1259.
10. Edmondson, D. G., W. Zhang, A. Watson, W. Xu, J. R. Bone, Y. Yu, D. Stillman, and S. Y. Roth. 1998. In vivo functions of histone acetylation/deacetylation in Tup1p repression and Gcn5p activation. Cold Spring Harbor Symp. Quant. Biol. 63:459-468.[CrossRef][Medline]
11. Feng, X., Y. Jiang, P. Meltzer, and P. M. Yen. 2000. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14:947-955.
12. Fischle, W., Y. Wang, and C. D. Allis. 2003. Binary switches and modification cassettes in histone biology and beyond. Nature 425:475-479.[CrossRef][Medline]
13. Fischle, W., Y. Wang, S. A. Jacobs, Y. Kim, C. D. Allis, and S. Khorasanizadeh. 2003. Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev. 17:1870-1881.
14. Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
15. Guenther, M. G., O. Barak, and M. A. Lazar. 2001. The smrt and n-cor corepressors are activating cofactors for histone deacetylase 3. Mol. Cell. Biol. 21:6091-6101.
16. Guenther, M. G., W. S. Lane, W. Fischle, E. Verdin, M. A. Lazar, and R. Shiekhattar. 2000. A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev. 14:1048-1057.
17. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.[CrossRef][Medline]
18. Huang, Z. Q., J. Li, L. M. Sachs, P. A. Cole, and J. Wong. 2003. A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J. 22:2146-2155.[CrossRef][Medline]
19. Jacobson, R. H., A. G. Ladurner, D. S. King, and R. Tjian. 2000. Structure and function of a human TAFII250 double bromodomain module. Science 288:1422-1425.
20. Jenuwein, T., and C. D. Allis. 2001. Translating the histone code. Science 293:1074-1080.
21. Lachner, M., D. O'Carroll, S. Rea, K. Mechtler, and T. Jenuwein. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116-120.[CrossRef][Medline]
22. Li, J., Q. Lin, H. G. Yoon, Z. Q. Huang, B. D. Strahl, C. D. Allis, and J. Wong. 2002. Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol. Cell. Biol. 22:5688-5697.
23. Li, J., J. Wang, Z. Nawaz, J. M. Liu, J. Qin, and J. Wong. 2000. Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19:4342-4350.[CrossRef][Medline]
24. Li, S., C. Xu, and R. W. Carthew. 2002. Phyllopod acts as an adaptor protein to link the sina ubiquitin ligase to the substrate protein tramtrack. Mol. Cell. Biol. 22:6854-6865.
25. Matsuzawa, S. I., and J. C. Reed. 2001. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell 7:915-926.[CrossRef][Medline]
26. Nakayama, J., J. C. Rice, B. D. Strahl, C. D. Allis, and S. I. Grewal. 2001. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292:110-113.
27. Perissi, V., A. Aggarwal, C. K. Glass, D. W. Rose, and M. G. Rosenfeld. 2004. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116:511-526.[CrossRef][Medline]
28. Peters, A. H., D. O'Carroll, H. Scherthan, K. Mechtler, S. Sauer, C. Schofer, K. Weipoltshammer, M. Pagani, M. Lachner, A. Kohlmaier, S. Opravil, M. Doyle, M. Sibilia, and T. Jenuwein. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107:323-337.[CrossRef][Medline]
29. Pijnappel, W. W., D. Schaft, A. Roguev, A. Shevchenko, H. Tekotte, M. Wilm, G. Rigaut, B. Seraphin, R. Aasland, and A. F. Stewart. 2001. The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev. 15:2991-3004.
30. Roth, S. Y., J. M. Denu, and C. D. Allis. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70:81-120.[CrossRef][Medline]
31. Schreiber, S. L., and B. E. Bernstein. 2002. Signaling network model of chromatin. Cell 111:771-778.[CrossRef][Medline]
32. Sharma, D., and J. D. Fondell. 2002. Ordered recruitment of histone acetyltransferases and the TRAP/Mediator complex to thyroid hormone-responsive promoters in vivo. Proc. Natl. Acad. Sci. USA 99:7934-7939.
33. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41-45.[CrossRef][Medline]
34. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:599-606.
35. Turner, B. M. 2002. Cellular memory and the histone code. Cell 111:285-291.[CrossRef][Medline]
36. Vermeulen, M., M. J. Carrozza, E. Lasonder, J. L. Workman, C. Logie, and H. G. Stunnenberg. 2004. In vitro targeting reveals intrinsic histone tail specificity of the Sin3/histone deacetylase and N-CoR/SMRT corepressor complexes. Mol. Cell. Biol. 24:2364-2372.
37. Wen, Y. D., V. Perissi, L. M. Staszewski, W. M. Yang, A. Krones, C. K. Glass, M. G. Rosenfeld, and E. Seto. 2000. The histone deacetylase-3 complex contains nuclear receptor corepressors. Proc. Natl. Acad. Sci. USA 97:7202-7207.
38. Wu, J., N. Suka, M. Carlson, and M. Grunstein. 2001. TUP1 utilizes histone H3/H2B-specific HDA1 deacetylase to repress gene activity in yeast. Mol. Cell 7:117-126.[CrossRef][Medline]
39. Xin, H., H. G. Yoon, P. B. Singh, J. Wong, and J. Qin. 2004. Components of a pathway maintaining histone modification and HP1 binding at the pericentric heterochromatin in mammalian cells. J. Biol. Chem. 279:9539-9546.
40. Xue, Y., J. Wong, G. T. Moreno, M. K. Young, J. Cote, and W. Wang. 1998. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell 2:851-861.[CrossRef][Medline]
41. Yoon, H. G., D. W. Chan, Z. Q. Huang, J. Li, J. D. Fondell, J. Qin, and J. Wong. 2003. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1. EMBO J. 22:1336-1346.[CrossRef][Medline]
42. Yoon, H. G., D. W. Chan, A. B. Reynolds, J. Qin, and J. Wong. 2003. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol. Cell 12:723-734.[CrossRef][Medline]
43. Yu, J., Y. Li, T. Ishizuka, M. G. Guenther, and M. A. Lazar. 2003. A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J. 22:3403-3410.[CrossRef][Medline]
44. Zhang, J., M. Kalkum, B. T. Chait, and R. G. Roeder. 2002. The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9:611-623.[CrossRef][Medline]
45. Zhang, Y., R. Iratni, H. Erdjument-Bromage, P. Tempst, and D. Reinberg. 1997. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 89:357-364.[CrossRef][Medline]
46. Zhang, Y., G. LeRoy, H. P. Seelig, W. S. Lane, and D. Reinberg. 1998. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell 95:279-289.[CrossRef][Medline]
47. Zhang, Y., H. H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924-1935.
48. Zhang, Y., and D. Reinberg. 2001. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15:2343-2360.
This article has been cited by other articles: